From top to bottom: a), b) Strong CD34 immunoreactivity (CD34, 40x).
Pathology
Monotonous storiform pattern of uniform, cytologically bland spindle cells, with a characteristic honeycomb pattern of infiltration into the subcutaneous fat. Immunohistochemical staining demonstrates strong positivity for vimentin and CD34 and negativity for factor XIIIa staining. Apolipoprotein has also been described as a marker for DFSP.
Treatment
Preferred treatment for DFSP is wide surgical excision with pathologically negative margins. Recently Imatinib mesylate therapy has been documented to induce extensive regression of primary and metastatic lesions.
Prognosis
Despite the local invasiveness, DFSP rarely metastasizes. The risk for development of metastatic disease is only 5%. The extent of surgical excision determines the prognosis of the patient. To reduce the local recurrence rate, a wide surgical excision with adequate margins is used.
Cytogenetics

Cytogenetics Morphological
Cytogenetically, DFSP is characterized by the presence of the recurrent t(17;22)(q22;q13) translocation or, more commonly, supernumerary ring chromosomes containing material from chromosomal regions 17q22 and 22q13 accompanied by simple chromosome trisomies. The translocation results in the fusion of the alpha chain type 1 of collagen (COL1A1) gene with the platelet-derived growth factor Beta (PDGFbeta) gene.
Cytogenetics Molecular
Fluorescence in situ hybridization based approaches can be used to demonstrate the t(17;22), using gene specific probes to demonstrate PDGFbeta gene rearrangements as well as genetic gains and losses.
FISH of a DFSP case using a break-apart probe to the PDGFB locus shows tumor cells with one yellow signal indicating an intact PDGFB locus, and two or more green signals, representing additional copies of an unbalanced rearranged PDGFB locus (x100). 
Genes involved and proteins
COL1A1
Result of the chromosomal anomaly
Fusion Protein
Note COL1A1 and PDGFbeta both encoded as pro-peptides are processed by proteolytic cleavage at N and Cterminus to give mature proteins. Sequences analyses of the chimerical COL1A1/PDGFbeta fusion transcripts has shown that the COL1A1/PDGFbeta putative proteins exhibit a pro-peptide structure, with a preserved N-terminus COL1A1 pro-peptide containing the signal peptide and the N and C-terminus PDGFbeta maturation cleavage sites. The result of this characteristic rearrangement of COL1A1and PDGFbeta is the transcriptional up-regulation of the PDGFB gene. The associated COL1A1-PDGFbeta fusion protein is posttranslationally processed to a functional PDGFbeta and results in PDGFbeta-mediated autocrine and/or paracrine activation of platelet-derived growth factor receptor-beta (PDGFBB).
